Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare the safe read-only, idempotent profile, so the bar is lower; the description adds real value by disclosing the methodology, the composite/confidence framing, and an explicit caveat that this is an automated estimate and NOT a target price or investment recommendation. It does not contradict any annotation.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Is the description appropriately sized, front-loaded, and free of redundancy?

Front-loaded with purpose and models, then outputs, then the optional tuning, ending with the critical disclaimer. Every sentence earns its place, though the output enumeration slightly duplicates the output schema.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

For a three-param valuation tool with an output schema that defines the return shape, the description is nearly complete. The only omission is explicit guidance on when this estimate should be preferred over sibling signals or consensus tools.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100% and the schema itself documents the ticker format and the default values for discount rate and terminal growth. The description only reiterates that these two are optionally adjustable, adding no format or unit detail beyond the schema, so the baseline 3 applies.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Does the description clearly state what the tool does and how it differs from similar tools?

States a specific verb and resource (fair value for a company) and enumerates the three concrete valuation models used (DCF, Gordon Growth DDM, EV/EBITDA). It also names the outputs (composite fair value per share, P/FV ratio, model outputs, confidence). This is far more specific than sibling valuation-adjacent tools and can be told apart without opening the schema.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Does the description explain when to use this tool, when not to, or what alternatives exist?

Usage is implied by the purpose (call it when you want an automated fair-value estimate) and the disclaimer hints at how to frame the result, but there is no explicit when-to-use, when-not-to-use, or reference to alternatives such as analyst consensus or factor models among the many siblings. It is adequate but leaves routing to inference.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.